Skip to content
Check Screen Reader Mode to make this survey compatible with screen readers.
Check Screen Reader Mode to make this survey compatible with screen readers.
2023 Texas ACS JAM | Breakout I: Breast & Surgical Oncology
Only Fellows, Associate, Retired, and Senior members eligible to score each session.
0 is the lowest; 5 is the highest
Have a conflict with a presentation, please mark N/A
We appreciate you taking the time to score the session.
OK
AN ULTRASOUND-BASED SCORING SYSTEM TO STRATIFY RISK OF AXILLARY METASTASIS IN BREAST CANCER
Spencer Van Decar MD
Brooke Army Medical Center, San Antonio
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
EVALUATION OF INDOCYANINE GREEN INJECTION FOR SENTINEL LYMPH NODE IDENTIFICATION IN BREAST CANCER PATIENTS WITH LYMPHATIC DISRUPTION
Erika Nourishirazi MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
DISPARITIES IN RECEIPT OF GUIDELINE CONCORDANT ADJUVANT RADIATION AFTER BREAST CONSERVING SURGERY FOR EARLY STAGE BREAST CANCER
Gloria Chang MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
DEMOGRAPHICS, CLINICAL PRESENTATION, AND OUTCOMES OF HIV INFECTED AND UNINFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA
Lucia Zhang BS, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH PANCOAST TUMORS: A NATIONAL CANCER DATABASE ANALYSIS
Jessica Cox MS, University of Texas Medical Branch - Galveston, Galveston
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
SERUM IL-6 LEVEL PREDICTS SURVIVAL AND TREATMENT RESPONSE IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCER
John Karalis MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
RESULTS OF A PHASE I TRIAL OF NEOADJUVANT PALLOV-CC VACCINE IN COLORECTAL CANCER
Ankur Tiwari MBBS, University of Texas Medical Center - San Antonio, San Antonio
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
PROGNOSTIC VALUE AND SURVIVAL OF POSITIVE-MARGIN RESECTIONS FOR PANCREATIC ADENOCARCINOMA IN THE ERA OF NEOADJUVANT THERAPY
Amr Al Abbas MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
EVALUATION OF SURVEILLANCE INTERVALS IN HIGH-RISK INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS THAT MAXIMIZES RESECTION OF MALIGNANCY
Menghan Zhao MD, University of Texas HSC - Houston, Houstons
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
DELINEATING THE ROLE OF SOCIAL VULNERABILITY IN COLORECTAL CANCER TREATMENT AND SURVIVAL
Gilbert Murimwa, MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
PREDICTORS AND BENEFITS OF MULTIAGENT CHEMOTHERAPY FOR PANCREATIC ADENOCARCINOMA: TIMING MATTERS
Todd Smolinksy MD, Brooke Army Medical Center, San Antonio
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
COST ANALYSIS AND FINANCIAL IMPLICATIONS OF CYTOREDUCTIVE SURGERY AND HIPEC: A US SINGLE CENTER EXPERIENCE
Andres Abreu MD, University of Texas Southwestern Medical Center, Dallas
0
1
2
3
4
5
N/A
Organization & Structure
0
1
2
3
4
5
N/A
Significance Score
0
1
2
3
4
5
N/A
Originality Score
0
1
2
3
4
5
N/A
Methodology Score
0
1
2
3
4
5
N/A
Results Score
0
1
2
3
4
5
N/A
Quality of Presentation Score
0
1
2
3
4
5
N/A
Visuals Score
0
1
2
3
4
5
N/A
Response to Questions Score
0
1
2
3
4
5
N/A
Current Progress,
0 of 12 answered